People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MIVI Neuroscience, Inc. | — | Other Health Care | Series C | $67.4M | $4.3M | 2020 |
Robert Colloton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Colloton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frederic Moll | 1 | 10 |
| FRED MOLL | 1 | 8 |
| Robert Stern | 1 | 6 |
| Maurice Ferre | 1 | 5 |
| Christopher Dewey | 1 | 4 |
| James McCollum | 1 | 3 |
| George Fazio | 1 | 3 |
| Christopher Geyen | 1 | 3 |
| Taylor Whitman | 1 | 3 |
| Sean Cheng | 1 | 2 |
| John O'Meara | 1 | 1 |
| Craig Yeshion | 1 | 1 |
| Nathan Harrington | 1 | 1 |
| Tim Hauch | 1 | 1 |
| Chris Dewey | 1 | 1 |
| Craig Yeshton | 1 | 1 |
| Benjamin Constable | 1 | 1 |
| Matthew Ogle | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.